TLRY - Tilray, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
6.96
-0.05 (-0.71%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous close7.01
Open7.15
Bid0.00 x 1300
Ask0.00 x 2200
Day's range6.89 - 7.28
52-week range2.43 - 48.48
Volume4,180,478
Avg. volume11,039,020
Market cap869.04M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-4.61
Earnings date11 May 2020
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est8.58
  • Which of These 2 Ultra-Growth Stocks Is Best?
    Motley Fool

    Which of These 2 Ultra-Growth Stocks Is Best?

    The best defense during a market downturn is usually a good offense. Here are two high-growing cannabis companies that are likely to continue their momentum.

  • Better Buy: Aphria vs. Tilray
    Motley Fool

    Better Buy: Aphria vs. Tilray

    Today, we'll look at which of the two leading companies in the marijuana sector, Aphria (NASDAQ: APHA) and Tilray (NASDAQ: TLRY), is a better buy right now. During the first quarter of 2020, Tilray recognized $52.1 million in revenue, a rise of 126% year over year. Although that growth is spectacular, the company is not profitable -- it recorded a net loss of $184 million, largely due to non-cash adjustments to the fair value of its warrants.

  • Despite Doubling, These Cannabis Stocks Are Bad News
    Motley Fool

    Despite Doubling, These Cannabis Stocks Are Bad News

    If you think the stock market has had a wild go of things lately, take a gander at marijuana stocks over the past three years. Until the end of the first quarter of 2019, pot stocks were virtually unstoppable. It was not uncommon for cannabis stocks to have delivered triple-digit or quadruple-digit gains to their shareholders.

  • 3 Pot Stocks to Stay Miles Away From
    Motley Fool

    3 Pot Stocks to Stay Miles Away From

    There are good marijuana stocks out there, but these Canadian cannabis companies have serious red flags.

  • Is Tilray Stock a Buy?
    Motley Fool

    Is Tilray Stock a Buy?

    The pot company's coming off a quarter where it reported a staggering loss of more than $184 million.

  • Business Wire

    Tilray, Inc. to Participate in Two Upcoming Virtual Investor Events

    Tilray, Inc., ("Tilray" or the "Company") (Nasdaq: TLRY) a global leader in cannabis research, cultivation, production and distribution, today announced that management will participate in the following upcoming virtual investor events:

  • Why Tilray Stock Surged 22.4% in May
    Motley Fool

    Why Tilray Stock Surged 22.4% in May

    The cannabis company delivered better-than-expected results and got a further boost from a big state moving towards legalization.

  • Canopy Growth CEO says new data on cannabis beverages show they can be bigger than hard seltzer
    Yahoo Finance

    Canopy Growth CEO says new data on cannabis beverages show they can be bigger than hard seltzer

    Despite recent troubles, Canopy Growth is optimistic its cannabis beverages can dwarf the growth of hard seltzers.

  • Cannabis company Canopy has a decade-long tailwind: Analyst
    Yahoo Finance

    Cannabis company Canopy has a decade-long tailwind: Analyst

    Shares of Canopy growth (CGC) are trading 30% lower since its latest quarterly results last week. However one analyst sees share as undervalued for the Canadian cannabis company which has shifted from medical to more recreational sales when that market was legalized in Canada almost two years ago. “Although we expect the medical market to shrink because of recreational legalization, we forecast more than 10% average annual growth for the entire Canadian market through 2030, driven by the conversion of black-market consumers into the legal market and new cannabis consumers,” analyst Kristoffer Inton wrote in a note to investors.

  • Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?
    Zacks

    Are Options Traders Betting on a Big Move in Tilray (TLRY) Stock?

    Investors need to pay close attention to Tilray (TLRY) stock based on the movements in the options market lately.

  • Why Tilray and OrganiGram Holdings Got Slammed on Friday
    Motley Fool

    Why Tilray and OrganiGram Holdings Got Slammed on Friday

    A pair of marijuana stocks, Tilray (NASDAQ: TLRY) and OrganiGram Holdings (NASDAQ: OGI), both dropped notably in price on Friday (by 5.2% and 7%, respectively). The culprit seems to be another weed title, Canopy Growth (NYSE: CGC), which earlier in the day published an awful quarterly earnings release. Canopy Growth is a leading company in the sector.

  • Cannabis ETF Tops in May: 5 Stocks That Led The Way
    Zacks

    Cannabis ETF Tops in May: 5 Stocks That Led The Way

    Inside the best performing stocks in the top cannabis ETF of May.

  • Tilray® Receives Complete GMP Certification at EU Campus
    Business Wire

    Tilray® Receives Complete GMP Certification at EU Campus

    Tilray, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced its wholly-owned subsidiary Tilray Portugal, Unipessoal Lda. ("Tilray Portugal") has received a Good Manufacturing Practice (GMP) certification in accordance with European Union standards, for its manufacturing facility in Cantanhede, Portugal. The GMP certification was issued by Infarmed, the Portuguese National Authority of Medicines and Health Products which provides end-to-end GMP certification for Tilray’s current operations in Portugal.

  • Tilray® Announces Optimization Plan for Adult-Use Facilities in Canada
    Business Wire

    Tilray® Announces Optimization Plan for Adult-Use Facilities in Canada

    Tilray, Inc. ("Tilray" or "the Company") (NASDAQ: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced its wholly-owned subsidiary High Park Gardens ("Natura Naturals Inc.") will close its doors over the course of the next six weeks. As a result of the closure, the Company expects to realize annualized net savings of approximately $7.5 million (current production costs net of future 3rd party purchases and ongoing depreciation) and avoid significant ongoing capital expenditures.

  • Tilray (TLRY) Catches Eye: Stock Jumps 6.3%
    Zacks

    Tilray (TLRY) Catches Eye: Stock Jumps 6.3%

    Tilray (TLRY) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

  • Tilray's CEO Expects at Least a Dozen Cannabis Bankruptcies in 2020 -- Is He Right?
    Motley Fool

    Tilray's CEO Expects at Least a Dozen Cannabis Bankruptcies in 2020 -- Is He Right?

    Canadian cannabis company Tilray's (NASDAQ: TLRY) CEO believes that at least 12 marijuana companies will go under this year. In March, Tilray announced that it would be raising $90.4 million through an offering, largely because the company still could. CEO Brendan Kennedy told BNN Bloomberg that he "wasn't sure anyone was going to be able to raise any money in this industry again" and that "when we had the opportunity to strengthen the balance sheet, we did."

  • Why Aurora Cannabis Stock Plunged Today
    Motley Fool

    Why Aurora Cannabis Stock Plunged Today

    Multiple factors could weigh on marijuana sales and make it harder for Aurora to achieve near-term profitability.

  • Tilray Inc (TLRY) Q1 2020 Earnings Call Transcript
    Motley Fool

    Tilray Inc (TLRY) Q1 2020 Earnings Call Transcript

    Ladies and gentlemen, thank you for standing by, and welcome to Tilray's First Quarter 2020 Earnings Conference Call. Good afternoon, and thank you for joining us on Tilray's first quarter 2020 earnings conference call and webcast. On with me today are Brendan Kennedy, Chief Executive Officer; and Michael Kruteck, Chief Financial Officer.

  • Tilray Drops Nearly 6% in After-Hours Trading Following Q1 Report
    Motley Fool

    Tilray Drops Nearly 6% in After-Hours Trading Following Q1 Report

    The cannabis company managed to narrow its net loss on a quarter-over-quarter basis, but that loss was still considerable.

  • Why Tilray's Revenue Soared and Its Loss Widened in Q1
    Motley Fool

    Why Tilray's Revenue Soared and Its Loss Widened in Q1

    Tilray's (NASDAQ:TLRY) 55% year-to-date loss is, without question, really bad. But it could have been much worse. Actually, it was much worse. At one point in March, Tilray had plunged nearly 90%.

  • Tilray Inc (TLRY) Reports Q1 Loss, Tops Revenue Estimates
    Zacks

    Tilray Inc (TLRY) Reports Q1 Loss, Tops Revenue Estimates

    Tilray Inc (TLRY) delivered earnings and revenue surprises of -11.36% and 4.85%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

  • Tilray, Inc. Reports First Quarter 2020 Financial Results
    Business Wire

    Tilray, Inc. Reports First Quarter 2020 Financial Results

    Tilray, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY), a global pioneer in cannabis research, cultivation, production and distribution, reports financial results for the first quarter ended March 31, 2020. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

  • Retail sales, Fed Chair Jerome Powell speaks: What to know in the week ahead
    Yahoo Finance

    Retail sales, Fed Chair Jerome Powell speaks: What to know in the week ahead

    COVID-19 and its impact on the U.S. economy will continue to take centerstage in the week ahead.

  • Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know
    Zacks

    Tilray, Inc. (TLRY) Gains As Market Dips: What You Should Know

    Tilray, Inc. (TLRY) closed the most recent trading day at $7.41, moving +0.27% from the previous trading session.

  • Why Tilray Stock Gained 17% in April
    Motley Fool

    Why Tilray Stock Gained 17% in April

    What happened Tilray (NASDAQ: TIL) shareholders outperformed a strong market last month. The stock rose 17% compared to a 13% increase in the S&P 500, according to data provided by S&P Global Market Intelligence.